Literature DB >> 24852721

Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013--recommendations.

.   

Abstract

This article presents the World Health Organizations (WHO) evidence and recommendations for the use of yellow fever (YF) vaccination from "Vaccines and vaccination against yellow fever: WHO Position Paper - June 2013" published in the Weekly Epidemiological Record. This position paper summarizes the WHO position on the use of YF vaccination, in particular that a single dose of YF vaccine is sufficient to confer sustained life-long protective immunity against YF disease. A booster dose is not necessary. The current document replaces the position paper on the use of yellow fever vaccines and vaccination published in 2003. Footnotes to this paper provide a number of core references. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the recommendations of WHO's Strategic Advisory Group of Experts (SAGE) on immunization. These recommendations were discussed by SAGE at its April 2013 meeting. Evidence presented at the meeting can be accessed at http://www.who.int/immunization/sage/previous/en/index.html.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Position paper; Vaccine; WHO; Yellow fever

Mesh:

Substances:

Year:  2014        PMID: 24852721     DOI: 10.1016/j.vaccine.2014.05.040

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

Review 1.  [What is verified for travel vaccinations?]

Authors:  Tomas Jelinek
Journal:  Internist (Berl)       Date:  2018-12       Impact factor: 0.743

2.  Differences between coverage of yellow fever vaccine and the first dose of measles-containing vaccine: A desk review of global data sources.

Authors:  Nedghie Adrien; Terri B Hyde; Marta Gacic-Dobo; Joachim Hombach; Akshaya Krishnaswamy; Philipp Lambach
Journal:  Vaccine       Date:  2019-06-29       Impact factor: 3.641

3.  Yellow Fever 17DD Vaccine Virus Infection Causes Detectable Changes in Chicken Embryos.

Authors:  Pedro Paulo de Abreu Manso; Barbara C E P Dias de Oliveira; Patrícia Carvalho de Sequeira; Yuli Rodrigues Maia de Souza; Jessica Maria dos Santos Ferro; Igor José da Silva; Luzia Fátima Gonçalves Caputo; Priscila Tavares Guedes; Alexandre Araujo Cunha dos Santos; Marcos da Silva Freire; Myrna Cristina Bonaldo; Marcelo Pelajo-Machado
Journal:  PLoS Negl Trop Dis       Date:  2015-09-15

Review 4.  Yellow fever vaccine and risk of developing serious adverse events: a systematic review.

Authors:  Ruben Porudominsky; Eduardo H Gotuzzo
Journal:  Rev Panam Salud Publica       Date:  2018-06-05

Review 5.  What Constitutes Protective Immunity Following Yellow Fever Vaccination?

Authors:  Jolynne Mokaya; Derick Kimathi; Teresa Lambe; George M Warimwe
Journal:  Vaccines (Basel)       Date:  2021-06-18

6.  Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype.

Authors:  Séverine Mercier-Delarue; Christine Durier; Nathalie Colin de Verdière; Jean-Dominique Poveda; Vincent Meiffrédy; Maria Dolores Fernandez Garcia; Stéphane Lastère; Raymond Césaire; Jean-Claude Manuggera; Jean-Michel Molina; Ali Amara; François Simon
Journal:  PLoS One       Date:  2017-05-31       Impact factor: 3.240

7.  The additional benefit of residual spraying and insecticide-treated curtains for dengue control over current best practice in Cuba: Evaluation of disease incidence in a cluster randomized trial in a low burden setting with intensive routine control.

Authors:  Maria Eugenia Toledo; Veerle Vanlerberghe; Julio Popa Rosales; Mayelin Mirabal; Pedro Cabrera; Viviana Fonseca; Tania Gómez Padrón; Mirtha Pérez Menzies; Domingo Montada; Patrick Van der Stuyft
Journal:  PLoS Negl Trop Dis       Date:  2017-11-08

8.  Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study.

Authors:  Valéria Valim; Ketty Lysie Libardi Lira Machado; Samira Tatiyama Miyamoto; Arthur Dalmaso Pinto; Priscila Costa Martins Rocha; Erica Vieira Serrano; Valquiria Garcia Dinis; Sônia Alves Gouvêa; João Gabriel Fragoso Dias; Ana Carolina Campi-Azevedo; Andréa Teixeira-Carvalho; Vanessa Peruhype-Magalhães; Ismael Artur da Costa-Rocha; Sheila Maria Barbosa de Lima; Emily Hime Miranda; Gisela Freitas Trindade; Maria de Lourdes de Sousa Maia; Maria Bernadete Renoldi de Oliveira Gavi; Lidia Balarini da Silva; Ruben Horst Duque; Ana Paula Espíndula Gianordoli; Thays Zanon Casagrande; Karine Gadioli Oliveira; Bruna Costa da Mata Moura; Fernanda Nicole-Batista; Luiza Correa Rodrigues; Thalles Brandão Clemente; Enan Sales Magalhães; Maria de Fatima Bissoli; Maria da Penha Gomes Gouvea; Lauro Ferreira da Silva Pinto-Neto; Carolina Zorzanelli Costa; Raquel Altoé Giovelli; Leticia Resende Brandão; Elizandra Tomazela Laurenti Polito; Ingrid de Oliveira Koehlert; Brunela Passos Borjaille; Daniela Bergamim Pereira; Laiza Hombre Dias; Daniela Linhares Merlo; Luiz Fellipe Favoreto Genelhu; Flavia Zon Pretti; Maryella Dos Santos Giacomin; Ana Paula Neves Burian; Francieli Fontana Sutile Tardetti Fantinato; Gecilmara Salviato Pileggi; Lícia Maria Henrique da Mota; Olindo Assis Martins-Filho
Journal:  Front Immunol       Date:  2020-07-17       Impact factor: 7.561

9.  Is a dose of 17D vaccine in the current context of Yellow Fever enough?

Authors:  Cassia Fernanda Estofolete; Mauricio Lacerda Nogueira
Journal:  Braz J Microbiol       Date:  2018-03-13       Impact factor: 2.476

10.  Knowledge Attitude and Practice (KAP) Study of Yellow Fever among International Students of Tehran University of Medical Sciences, Iran.

Authors:  Fatima Mahmud Muhammad; Hamidreza Basseri; Reza Majdzadeh; Khandan Shahandeh; Abbas Rahimi Foroushani
Journal:  Iran J Public Health       Date:  2019-07       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.